Interferon-γ Release Assay for the Diagnosis of Latent Mycobacterium tuberculosis Infection in Children Younger Than 5 Years

Abstract

Background. Interferon-γ release assays (IGRAs) have been widely used for the diagnosis of latent and active tuberculosis in adults, but their role in diagnosing latent tuberculosis infection (LTBI) in children younger than 5 years remains unclear. Objective. To evaluate the diagnostic performance of IGRAs for LTBI in children younger than 5 years. Methods. We searched the PubMed, EMBASE, Cochrane Library, and Web of Knowledge databases. According to inclusion criteria, the diagnostic studies of IGRAs for LTBI in children younger than 5 years were included. The study quality was assessed using the 14-item Quality Assessment of Diagnostic Accuracy Studies instrument. The Meta-Analyst software was used to analyze the data. Results. Seven studies (627 patients) were included. Meta-analysis showed that compared with tuberculin skin test (TST), the pooled sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value (PPV), negative predictive value (NPV), accuracy and diagnosis odds ratio (DOR), and summary receiver operating characteristic (SROC) curve of QuantiFERON-TB (values in parentheses are 95% confidence intervals) were 0.841 (0.733-0.911), 0.895 (0.861-0.922), 8.046 (5.953-10.876), 0.192 (0.113-0.326), 0.622 (0.527-0.709), 0.970 (0.946-0.983), 0.891 (0.861-0.916), 50.718 (24.201-106.287), and 0.809 respectively. The pooled Sen, Spe, PLR, NLR, PPV, NPV, accuracy, DOR, and SROC curve of T-SPOT.TB test were 0.931 (0.760-0.983), 0.767 (0.684-0.833), 3.947 (2.854-5.459), 0.095 (0.026-0.354), 0.523 (0.398-0.645), 0.977 (0.914-0.994), 0.806 (0.737-0.860), 65.270 (13.463-316.434), and 0.855, respectively. Conclusion. This meta-analysis showed that the sensitivity and specificity of IGRAs were slightly higher than TST and can be used as supporting tools to detect LTBI in children younger than 5 years. The methodological quality of diagnostic test needs to be improved.

Keywords

interferon-γ release assay children meta-analysis

Get full access to this article

View all access options for this article.

References

World Health Organization. Tuberculosis. http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed March 2012.

Singh

Saini

Anil

Aggarwal

. Latent tuberculosis in children: diagnosis and management. Indian J Pediatr. 2011;78:464-468.

Pavic

Topic

Raos

Aberle

Dodig

. Interferon-gamma release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age. Pediatr Infect Dis J. 2011;30:866-870.

Lodha

Kabra

. Newer diagnostic modalities for tuberculosis. Indian J Pediatr. 2004;71:221-227.

Sun

Xiao

Miao

. Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis. FEMS Immunol Med Microbiol. 2011;63:165-173.

Amdekar

. How to optimize current (available) diagnostic tests. Indian J Pediatr. 2011;78:340-344.

Dayal

Verma

Sharma

. Diagnostic value of interferon-gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis. Indian J Pediatr. 2012;79:183-187.

Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax. 2000;55:887-901.

Whiting

Weswood

Rutjes

AWS

Reitsma

Bossuyt

PNM

Kleijnen

. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:9.

10.

Walter

. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002;21:1237-1256.

11.

Dogra

Narang

Mendiratta . Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007;54:267-276.

12.

Kampmann

Whittaker

Williams

. Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J. 2009;33:1374-1382.

13.

Okada

Mao

Mori

. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect. 2008;136:1179-1187.

14.

Thomas

Pugalenthi

Patel

Woltmann

Bankart

Hoskyns

. Concordance between tuberculin skin test and interferon-(gamma) assay and interferon-(gamma) response to mitogen in pediatric tuberculosis contacts. Pediatr Pulmonol, 2011;46:1225-1232.

15.

Stefan

Dippenaar

Detjen

. Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer. Int J Tuberc Lung Dis. 2010;14:689-694.

16.

Nicol

Davies

Wood

. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics. 2009;123:38-43.

17.

Centers for Disease Control and Prevention. The difference between latent TB infection and TB disease. http://www.cdc.gov/tb/publications/factsheets/general/LTBIandActiveTB.htm. Accessed July 18, 2012.

18.

Swaminathan

. Role of interferon gamma release assays in childhood tuberculosis. Indian J Pediatr. 2012;79:250-252.

19.

Mandalakas

Detjen

Hesseling

Benedetti

Menzies

. Interferon gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15:1018-1032.

20.

Shi

Kang

Yang

. Interferon-gamma release assays for diagnosis of latent Mycobacterium tuberculosis infection in children: a meta-analysis. Chin J Evid Based Pediatr. 2010;5:263-269.